The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Cheers Trout
What i can tell you is that its the first test of its kind in the world and within minutes can save a baby's hearing. Its been tested already etc.
Would you regard the IHC network to get sales as significant and to the best of your knowledge do they deliver big numbers?
I have always took it as IHC would distribute the test to UK and Ireland. They would both market the product at launch and IHC's contacts would be able to help this test become the 'Gold Standard' and I also remember seeing something about IHC would work towards NICE guidance to use the product. Obviously there was mention of further distribution through IHC's International network and this has just got much bigger with the SLE acquisition. This from a month ago from Genedrive,
"
Despite some initial concerns around the impact of lockdown on the Antibiotic Induced Hearing Loss (AIHL) project, the NHS evaluation programme has continued to run during the past few months. After a slow period, the programme pace has increased somewhat as lock-down measures have eased and the Company remains optimistic of completing the project and achieving the Autumn 2020 timeframe for commercial launch with Inspiration Healthcare Plc."
Hello gents,
Just wondering whether you folks have any insights on how IHC operates and how the partnership with GDR works?
Is it a case of IHC manage the sales or is the role of IHC to allow partners to trial it etc and leave sales to GDR?
https://www.proactiveinvestors.co.uk/companies/news/918037/genedrive-and-inspiration-healthcare-to-distribute-neonatal-hearing-loss-test-in-uk--ireland-918037.html
Interview with CEO here, all sounding very positive, the 30% rise was LFL and doesn't include the NHS ventilator contracts of which £2m have been delivered in H1 with £3m to follow.
https://t.co/9P2uGnB7Me?amp=1
I hope you got a few more, as it looks like others are after them now.
I think the ambiguity of the statements and lack of understanding of what market expectations are led to a panic sell off yesterday, now the dust has settled I see more investors buying in to the IHC story.
How do IHC manage to write an RNS with 30% increase in sales in H1, but share price falls in early trading? Its because they wrote...
1) Only 40% ventillators sourced (although this was a one off order not expected before CV19, therefore a bonus!)
2) Increase in sales H1 biased.
These guys need to milk the positive news and gloss over the items which some investors (traders) will take to be negative news.
Last time the RNS was issued twice as the same thing happened.
Please BOD, get someone better to write your RNS results / trade updates - frustrating that we can't break 70p+
“the Group has continued to enjoy a very strong start to the year with underlying revenues in the first six months of the financial year circa 30 per cent ahead of those achieved in the same period last year.”
Great. Especially when complemented with a profitable acquisition to help further increase margins. Interesting to see when the share price reflects the current success.
Encouraging trading update today - confident in at least achieving expectations, and with a healthy order book in the core business augmented by COVID-19 opportunities.
In particular, the acquisition of SLE is going well, and the language remains bullish with talk of short and medium-term earnings enhancement:
Https://uk.advfn.com/stock-market/london/inspiration-healthcare-IHC/share-news/Inspiration-Healthcare-Group-PLC-Trading-Update/83042079
picked up a few more, this is undervalued considering the recent acquisition.
I think IHC have the perfect plan for growth without compromising business health. And yes, that's a capital idea to email him!
It's not the results that are expected, but a trading statement post H1.
The figures will be interesting as they have said there were good sales prior to and during the C19 outbreak. Not heard anymore about the last NHS ventilators to be delivered, so looks like the £5.25m sales figure will be split between H1 and H2.
Going forward looking very positive and well worth building on any investment here.
There will be huge demand for all healthcare equipment in my view. CV19 has made people realise the value of the NHS and they will be more happy to pay more taxes to fund better services in future. With neo-natal care, healthcare providers will spend whatever is needed to look after premature babies; no will argue that this spending is discretionary.
IHC just needs some good media coverage and someone like Simon Thompson at Investors Chronicle to champion. I might drop him an email, flagging up that results are due in the next week.
I have also been tempted to add more here. Volume is low, but this company is doing all the right things. It's clear in its long term aims to grow revenues to greater than £100mn through targeted acquisitions.
The only negative I can stretch to lies in their long term aim to be the leader in specifically neonatal care, with most health plays being based around the growing ageing population narrative. They say they expect an increasing number of births (such as premature) requiring their services and products, but, even if this is not true, as the world gets wealthier most likely more resources per birth will be mobilised anyway, thus still creating compelling growing demand for IHC.
The trade update is due next week (probably Thursday 13/8 if similar day to last year). I can't believe it will be anything other than good and should be one of the few companies to benefit from CV19 (ventillators and other supplies for NHS) Despite positive news from IHC and recent takeover of another profitable company (with oversubscribed fund raise at 65p), the share price is still langushing. For whatever reason this company seems to get very little media coverage, so daily volume is low. I've just added to my holding at crazy low price of 62.15p. Can't believe there isn't at least 25% upside here in a week. NB this isn't a CV19 all or nothing share, but a solid investment in a growing company that intends to pay a dividend next year and is already profitable. Good luck all holders.
Let’s hope their communications get better as this will rocket on the next rns Come on BOD get the great news out tgere
I think they have been busy integrating the new acquisition.
I expect to hear more about receipt of the outstanding NHS ventilators and we should get a Trading Update for H1 in the next fortnight. I have used the drop in SP to add a couple of times this week, I am happy to keep accruing as the BoD seem very capable and the Company's products will always be in demand.
What exactly do you want them to tell you?
Looking at what they have achieved including during the ventilator challenge then they seem a pretty good board to me. What was it that attracted you to this company - seems to be the same people ever since they joined AIM.
Now done two other TOs plus distribution deals. The SP will move around a bit but probably not as volatile as others.
This BOD seem clueless
Show some loyalty and respect for your shareholders who supported your share offering
Oversubscribed and then dropped like a stone
What is wrong with you people on the board. Some info would be good in fact any communication would be a start
Do your jobs and start a dialogue with your shareholders or get some descent directors who can!!!
Indeed and today seems a day of rollovers and transfers.
Today's RNS is odd as well, why did Miton buy in the placing and then sell some of them yesterday at a loss?
Oversubscribed rights issue, positive news a plenty and the price drops with no buys?
I'm with HL and confused by the situation. I seem to have received all the shares I applied for which cannot be correct?
I have now been told the money from the shares not allocated will take 2 weeks to hit my account
What a farce,,,,
Looks like we have been taken as Mug’s
Thanks BOD for relieving me of my money and HL for being totally useless and unprofessional
So looks like all the raft of TR1's are the impact on the recent placing diluting various holdings & in reality no change ?
HL still not allocated my shares despite indicating in my share account the total amount applied for and the total cost
Really not very professional
No idea